Santa Rosa Memorial Hospital Regional CCOP

描述（由申请人提供）：圣罗莎纪念医院CCOP（SRMH CCOP）是一个核心肿瘤学家小组密集开发的结果，该小组为北方加州相对孤立的五个县地区80%的癌症患者提供服务。16名医学和放射肿瘤学家组成了雷德伍德地区医疗集团，每年接待2800多名新患者。在上一个资助期内，两个新的附属机构加入了SRMH CCOP，增加了五名肿瘤学家并扩大了地理覆盖区域，从而确保有足够的患者人群进行临床试验累积。SRMH CCOP提供所需的支持，以增加其服务的五个县获得最新癌症治疗和控制研究方案的机会。患者人群包括大量服务不足的农村、种族和社会经济弱势群体，CCOP为他们提供最先进的治疗。我们的计划系统地汇集了必要的资源：训练有素的肿瘤学家，具有合作组临床试验经验的专家数据管理人员，高质量控制标准，医院资源承诺和非肿瘤专家的参与。临床研究团队开发了一种有效的病例发现方法，确保实现CCOP目标。特别值得注意的是，该计划在癌症控制方面取得了非常成功的记录，导致168人注册参加PCPT试验，40名患者注册参加星星试验。作为指定的SELECT研究中心，我们今年已登记了28名患者参加这项研究。CCOP计划今年至少登记40名患者到SELECT，10名患者到星星。

DESCRIPTION (provided by applicant): The Santa Rosa Memorial Hospital CCOP(SRMH CCOP) is the result of intensive development by a core group of oncologists who serve 80% of the cancer patients in a relatively isolated five county area in Northern California. The sixteen medical and radiation oncologists who form the Redwood Regional Medical Group see over 2800 new patients per year. Two new affiliate sites have joined the SRMH CCOP during the last funding period, bringing an additional five oncologists and expanding the geographic catchment area thus ensuring an adequate patient population for clinical trials accrual. The SRMH CCOP provides the support needed to increase access to the latest cancer treatment and control research protocols in the five counties it serves. The patient population includes a significant number of underserved rural, ethnic and socio-economically disadvantaged individuals for whom the CCOP provides access to state-of-the-art treatment. Our program has systematically assembled the necessary resources: highly trained oncologists, an expert data management staff experienced with cooperative group clinical trials, high quality control standards, hospital resource commitments and involvement of non-oncology specialists. The clinical research team has developed an effective case-finding approach which ensures achievement of CCOP goals. Of particular note is the program's highly successful track record in cancer control accrual resulting in 168 persons being registered to the PCPT trial and 40 patients registered to the STAR trial. As a designated SELECT site, we have registered 28 patients to the study this year. The CCOP plans to register a minimum of 40 patients to SELECT and 10 patients to STAR this year.